Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06965296 · ClinicalTrials.gov registry record · NA
AI-Enhanced App-based Intervention for Adolescent E-cigarette Cessation
A NA study, sponsored by State University of New York at Buffalo.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT06965296 is a NA study that has not yet begun recruiting, run by State University of New York at Buffalo. The registered enrollment target is 100 participants.
The verdict
NCT06965296, a NA study, has not yet begun recruiting, sponsored by State University of New York at Buffalo.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The goal of this quasi-experimental study is to test if a smartphone app can help adolescents aged 14-20 quit e-cigarettes. The main questions it aims to answer are: * Can the app help adolescents manage cravings and increase their readiness to quit? * Does the personalized and real-time support provided by the app improve their success in quitting e-cigarettes? Researchers will compare two groups: an immediate-intervention group that starts using the app right away and a delayed-intervention group that begins after three months, to see if the timing of app access influences outcomes in e-cigarette cessation. Participants will: * Set personal goals and track their daily progress within the app. * Use a real-time "urge" feature that provides immediate support during cravings. * Engage with a chatbot for quick answers and motivational support around quitting. This study aims to create an accessible, personalized tool to help adolescents reduce or quit e-cigarette use, exploring its feasibility as a broader intervention model.
Interventions
- BEHAVIORAL AI-enhanced smartphone app
- BEHAVIORAL AI-enhanced smartphone app, but with delayed access
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06965296
The ClinicalTrials.gov registry entry for NCT06965296 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AI-enhanced smartphone app is the first listed.
NCT06965296 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06965296 about?
NCT06965296 is a clinical study titled "AI-Enhanced App-based Intervention for Adolescent E-cigarette Cessation". The goal of this quasi-experimental study is to test if a smartphone app can help adolescents aged 14-20 quit e-cigarettes. The main questions it aims to answer are: * Can the app help adolescents manage cravings and increase their readiness to quit? * Does the personalized and real-time support pr...
What is the current status of trial NCT06965296?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-08-01. Estimated completion is 2027-06-30.
What interventions are being tested in trial NCT06965296?
The interventions under investigation include: AI-enhanced smartphone app (BEHAVIORAL), AI-enhanced smartphone app, but with delayed access (BEHAVIORAL).
Who is sponsoring clinical trial NCT06965296?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.